Aliquots Archive
-
September 22, 2022
Reduced exercise capacity in ICU survivors
ICU survivors who have impaired exercise capacity months after discharge may have damaged muscle mitochondria — the energy powerhouses of the cell, Vanderbilt researchers propose. -
September 22, 2022
Nerve cells and cancer progression
Immature nerves and neural precursor cells increase in density as a type of premalignant tumor in the pancreas progresses to invasive disease, suggesting that blocking these cells may arrest malignant progression. -
September 13, 2022
Cancer registries and sarcoma research
The number of sarcoma research studies that use the two largest U.S. cancer registries is increasing, but over one-third of studies that asked the same research question reported conflicting findings. -
September 12, 2022
Enhancing innate immunity in the lung
Vanderbilt researchers show that a TLR4 agonist improves lung immune response and survival in a mouse model of bacterial pneumonia, supporting the development of this drug to protect against pneumonia in hospitalized patients. -
September 8, 2022
PheWAS reveals post-COVID-19 diagnoses
Using a high-throughput informatics technique and electronic health records, Vanderbilt researchers found that COVID-19 survivors had an increased risk for more than 40 new diagnoses. -
September 8, 2022
Immune cells drive beta cell loss in Type 2 diabetes
Vanderbilt researchers have discovered details of pancreatic beta cell loss — and potential therapeutic targets — during conditions of overnutrition, as occurs in obesity. -
August 30, 2022
A new mechanism for lupus
Vanderbilt researchers describe a new mechanism for the most common form of lupus and suggest a new treatment approach to this autoimmune disease.